Literature DB >> 12228027

Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.

Larry M. Baddour1.   

Abstract

Entities:  

Year:  2002        PMID： 12228027     DOI： 10.1007/s11908-002-0007-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  4 in total

1.  Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.

Authors:  A Gough; M Clapperton; N Rolando; A V Foster; J Philpott-Howard; M E Edmonds
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

2.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

Authors:  L M Souza; T C Boone; J Gabrilove; P H Lai; K M Zsebo; D C Murdock; V R Chazin; J Bruszewski; H Lu; K K Chen; J Barendt; E Platzer; M A S Moore; R Mertelsmann; K Welte
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection.

Authors:  A Yönem; B Cakir; S Güler; O Azal O; A Corakçi
Journal:  Diabetes Obes Metab       Date:  2001-10       Impact factor: 6.577

4.  Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus.

Authors:  W Marhoffer; M Stein; L Schleinkofer; K Federlin
Journal:  Diabetes Res Clin Pract       Date:  1993-03       Impact factor: 5.602
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.